Advertisement

Topics

Latest "Schwan’s Company" News Stories

10:10 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Schwan’s Company" found in our extensive news archives from over 250 global news sources.

More Information about Schwan’s Company on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Schwan’s Company for you to read. Along with our medical data and news we also list Schwan’s Company Clinical Trials, which are updated daily. BioPortfolio also has a large database of Schwan’s Company Companies for you to search.

Showing "Schwan Company" News Articles 1–25 of 18,000+

Friday 15th February 2019

Company Profile for Novus Therapeutics, Inc.

Novus Therapeutics, Inc. (“Novus”) is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”). Novus has two technologies, each that has the potential to be developed for multiple ENT indications. Novus’ lead product candidate (OP0201) is a surfactant-based, drug-device co...


AXOGEN SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AxoGen, Inc. - AXGN

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 11, 2019 to file lead plaintiff applications in a securities class action lawsuit against AxoGen, Inc. (NasdaqCM: AXGN), if they purchased the Company’s securities in connection with its November 2017 or May 2018 secondary public offering or between August 7...

Aradigm Announces Plans for Reorganization Under Chapter 11 of the U.S. Bankruptcy Code

Aradigm Corporation (OTCQB: ARDM) (“Aradigm” or the “Company”) has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the Alameda County Court District to facilitate the sale of its assets. On February 11, 2019, Aradigm determined that without confirmation of funding from their primary investor and partner, the Company would not...


Antibe Therapeutics Reports Q3 2019 Interim Financial and Operating Results

Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF) filed its financial and operating results on Friday, February 15th for the fiscal quarter ended December 31, 2018. The Company’s unaudited fiscal Q3 2019 condensed interim consolidated financial statements and MD&A are available on SEDAR. About Antib...

TransCanna Announces Corporate Update Conference Call

Vancouver, British Columbia--(Newsfile Corp. - February 15, 2019) - TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") intends to host a corporate update conference cal...

Kiadis Pharma Notice of Extraordinary General Meeting of Shareholders

                                                                  Amsterdam, The Netherlands, 15 February 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that it has convened an extraor...

Vivacelle Bio, Inc. Receives FDA Clearance to Enroll Patients into its Phase IIa Clinical Trial of VBI-1 for Severe Blood Loss and/or Raising Blood Pressure in Hypovolemic Subjects

Vivacelle Bio, Inc. today announces that the US. Food and Drug Administration (FDA) has granted it an Investigational New Drug (IND) clearance to proceed with its phase IIa clinical trial of the safety and efficacy of VBI-1. VBI-1 is a paradigm-changing cardiovascular support fluid that is designed for the treatment of patients with emergently life-threate...

Cross Country Healthcare to Present at Barclays Global Healthcare Conference and Oppenheimer’s 29th Annual Healthcare Conference

Cross Country Healthcare, Inc. (Nasdaq: CCRN) announced today that it is scheduled to present at two upcoming conferences: The Barclays Global Healthcare Conference on Wednesday, March 13, 2019 at 3:50 p.m. Eastern Time, at the Loews Miami Beach Hotel in Miami Beach, Florida. The Oppenheimer 29th Annual Healthcare Confe...

Tekla Healthcare Investors Declares Stock Distribution

On February 15, 2019, Tekla Healthcare Investors declared a stock distribution of $0.41 per share. The record date for the stock distribution is February 28, 2019 and the payable date is March 29, 2019. The Fund will trade ex-distribution on February 27, 2019. This stock distribution will automatically be paid in newly issued shares of the Fund un...

Agilent / DSO1072B / Oscilloscope, 70 MHz, 2 Analog Channels

£200.00 (0 Bids)End Date: Sunday Feb-17-2019 18:18:51 GMTBid now | Add to watch list Biotech365 : Agilent / DSO1072B / Oscilloscope, 70 MHz, 2 Analog Channels BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool … Continue reading →

HOOKIPA Appoints Michael A. Kelly as Independent Director.

New York, US and Vienna, Austria – 15 February 2019 – HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced the appointment of Michael A. Kelly to the Company’s Board of Directors. Mr. Kelly is a former senior exe...

Opdivo Plus Yervoy Shows Response in Pre-Treated Patients with Metastatic Castration-Resistant Prostate Cancer

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced data evaluating Opdivo(nivolumab) in combination with Yervoy (ipilimumab) in patients with metastatic castration-resistant prostate cancer (mCRPC). Results from an interim analysis of the Phase 2 CheckMate -650 trial showed that among 32 asymptomatic or minimally symptomatic pat...

Health-E Commerce Receives Majority Equity Investment from Beecken Petty O'Keefe & Company ("BPOC")

Health-E Commerce Is the Parent Company of Leading Health and Wellness E-Commerce Sites FSAstore.com, HSAstore.com and WellDeserved NEW YORK (PRWEB) February 15, 2019 Health-E Commerce, the parent company of the nation’s leading family of e-commerce brands dedicated to pre-tax health and wellness products and services, today announced that it has received a majority equity investment from Beeck...

HOOKIPA Appoints Michael A. Kelly as Independent Director

HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced the appointment of Michael A. Kelly to the Company’s Board of Directors. Mr. Kelly is a former senior executive of Amgen, Inc. currently acting as Foun...

Pharmalot.. Pharmalittle.. Good Morning.. Company buys drug and raises price 70%, Oklahoma opioid trial is the one to watch & more news.. plus, weekend daydreams.. https://www.statnews.com/pharmalot/2019/02/15/drug-prices-opioids-oklahoma-trial/ … #ph

Pharmalot.. Pharmalittle.. Good Morning.. Company buys drug and raises price 70%, Oklahoma opioid trial is the one to watch & more news.. plus, weekend daydreams.. https://www.statnews.com/pharmalot/2019/02/15/drug-prices-opioids-oklahoma-trial/ … #pharma #drugprices #opioids

STAT Plus: Pharmalittle: Company buys drug and raises price 70 percent; Oklahoma opioid trial is the one to watch

The day after Egalet bought a pain reliever, the company boosted the price by 70 percent, which was the largest single brand price hike in over a year.

IIP Operating Partnership, LP Prices Private Offering of $125 Million of 3.75% Exchangeable Senior Notes Due 2024

Innovative Industrial Properties, Inc. (the "Company") (NYSE: IIPR) announced today that its operating partnership subsidiary, IIP Operating Partnership, LP (the "Operating Partnership"), priced a private offering of $125 million aggregate principal amount of 3.75% Exchangeable Senior Notes due 2024 (the "Notes"). The Operating ...

More blood pressure services should be commissioned through community pharmacy, says Company Chemists’ Association

More blood pressure services should be commissioned through community pharmacy to support goals set out in the ‘NHS Long-Term Plan’, the Company Chemists’ Association has said.

Beiersdorf Aktiengesellschaft: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Beiersdorf Aktiengesellschaft / Preliminary announcement on the disclosure of financial statements 15.02.2019 / 10:22 Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. -------------------...

Herantis Pharma Plc is planning a directed share issue and prepares for a contemplated secondary listing on the First North Stockholm marketplace

Herantis Pharma Plc is planning a directed share issue to a limited number of investors and the company's directors and prepares for a contemplated secondary listing on the First North Stockholm marketplace Herantis Pharma Plc Company release 15 February 2019 at 9:00 am Not for publication or distribution, directly or indirectly, in or into Australia, South Africa, Hong Kong, Japa...

Herantis Pharma Oyj: Notice to convene Herantis Pharma Plc's Extraordinary General Meeting of shareholders

Notice to convene Herantis Pharma Plc's Extraordinary General Meeting of shareholders Herantis Pharma Plc Company release 15 February 2019 at 9:30 am NOTICE TO CONVENE HERANTIS PHARMA PLC'S EXTRAO...

Global Growth and Differentiation Factor 8 Market Data Survey Report 2025 [Report Updated: 01011970] Prices from USD $1500

SummaryThe global Growth and Differentiation Factor 8 market will reach Volume Million USD in 2018 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers manufacturing sites, capacity and production, product specifications etc.Major ApplicationMajor TypeKey manufacturers are included...

Perrigo hält Dividende stabil

Der irische Pharmakonzern Perrigo Company PLC (ISIN: IE00BGH1M568, NYSE: PRGO) kündigt eine Quartalsdividende in Höhe von 0,19 US-Dollar an. Die Ausschüttung erfolgt am 19. März 2019 (Record date: ...

#Cannabisstocks: Village Farms International's (TSX: VFF; OTCQX: VFFIF) Common Shares Approved for Listing on Nasdaq

VANCOUVER - February 15, 2019 (Investorideas.com Newswire) Village Farms International, Inc. ("Village Farms" or the "Company") (TSX:VFF; OTCQX: VFFIF) today announced that its common shares have been approved for listing on the Nasdaq Capital Market under the symbol "VFF".

Spring Pharmaceutical Group Inc. Reports Financial Results for the Three and Nine Months Ended December 31, 2018

JINING, China, Feb. 15, 2019 /PRNewswire/ -- Spring Pharmaceutical Group, Inc. (OTCQB: CYIG) ("Spring Pharmaceutical" or the "Company") today announced its financial results for the three and nine months ended December 31, 2018. Three Months Ended December 31, 2018 Financials Highlights Total revenues increased by 13.3% to $19.49 million with growth in sales across all thr...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks